U.S. flag

An official website of the United States government

NM_000388.4(CASR):c.680G>T (p.Arg227Leu) AND Neonatal severe primary hyperparathyroidism

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jul 3, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000008818.8

Allele description [Variation Report for NM_000388.4(CASR):c.680G>T (p.Arg227Leu)]

NM_000388.4(CASR):c.680G>T (p.Arg227Leu)

Gene:
CASR:calcium sensing receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q21.1
Genomic location:
Preferred name:
NM_000388.4(CASR):c.680G>T (p.Arg227Leu)
HGVS:
  • NC_000003.12:g.122261715G>T
  • NG_009058.1:g.83033G>T
  • NM_000388.4:c.680G>TMANE SELECT
  • NM_001178065.1:c.680G>T
  • NM_001178065.2:c.680G>T
  • NP_000379.3:p.Arg227Leu
  • NP_001171536.2:p.Arg227Leu
  • NC_000003.11:g.121980562G>T
  • NM_000388.4:c.680G>T
Protein change:
R227L; ARG227LEU
Links:
OMIM: 601199.0006; dbSNP: rs28936684
NCBI 1000 Genomes Browser:
rs28936684
Molecular consequence:
  • NM_000388.4:c.680G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178065.2:c.680G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Neonatal severe primary hyperparathyroidism
Synonyms:
Neonatal severe hyperparathyroidism
Identifiers:
MONDO: MONDO:0009397; MedGen: C1832615; Orphanet: 417; OMIM: 239200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000029028OMIM
no assertion criteria provided
Pathogenic
(Feb 1, 2005)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV005203731Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Jul 3, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.

Pearce SH, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hughes IA, Paterson CR, Whyte MP, et al.

J Clin Invest. 1995 Dec;96(6):2683-92.

PubMed [citation]
PMID:
8675635
PMCID:
PMC185975

Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism.

Wystrychowski A, Pidasheva S, Canaff L, Chudek J, Kokot F, Wiecek A, Hendy GN.

J Clin Endocrinol Metab. 2005 Feb;90(2):864-70. Epub 2004 Nov 30.

PubMed [citation]
PMID:
15572418
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000029028.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a sporadic case of neonatal hyperparathyroidism (NSHPT; 239200), Pearce et al. (1995) found a heterozygous CGA-to-CTA transversion in codon 227 of exon 4, resulting in an amino acid substitution of leucine for arginine (R227L).

Wystrychowski et al. (2005) performed a functional analysis comparing the R227L and R227Q mutations (see 601199.0049).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV005203731.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: CASR c.680G>T (p.Arg227Leu) results in a non-conservative amino acid change located in the Receptor, ligand binding region (IPR001828) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250970 control chromosomes (gnomAD). c.680G>T has been reported in the literature in an individual affected with Neonatal Hyperparathyroidism as a de novo occurrence (Pearce_1995), as well as in an individual affected with Familial Hypocalciuric Hypercalcemia (Veldeman_2020). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, finding that the variant results in impaired MAPK response to extracellular calcium levels (Wystrychowski_2005). The following publications have been ascertained in the context of this evaluation (PMID: 8675635, 15572418, 32306059). ClinVar contains an entry for this variant (Variation ID: 8317). Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024